Cardiovascular Disease
Showing NaN - NaN of 26
Dyslipidemia, Atherosclerosis, Acute Coronary Syndrome Trial in Dallas (RVX000222, Placebo)
Completed
- Dyslipidemia
- +3 more
- RVX000222
- Placebo
-
Dallas, TexasCovance Clinical Research Unit, Inc.
Nov 1, 2022
Patients With Heart Failure Using HeartLogic
Completed
- Heart Failure
- +5 more
- HeartLogic Sensors
-
Birmingham, Alabama
- +87 more
Oct 24, 2022
Heart Failure, Anemia, Cardiovascular Disease Trial in Worldwide (Darbepoetin alfa, Placebo)
Completed
- Heart Failure
- +4 more
- Darbepoetin alfa
- Placebo
-
Birmingham, Alabama
- +753 more
Oct 31, 2021
Anemia, Cardiovascular Disease Trial in Dallas (EPO, Feraheme)
Terminated
- Anemia
- Cardiovascular Disease
-
Dallas, Texas
- +1 more
Oct 21, 2020
Cardiovascular Disease Trial in Canada, Puerto Rico, United States (Methotrexate, Placebo)
Cardiovascular Disease Trial in Worldwide (Dalcetrapib, Placebo)
Terminated
- Cardiovascular Disease
- Dalcetrapib
- Placebo
-
Los Angeles, California
- +109 more
Mar 20, 2020
Cardiovascular Disease, Diabetes, Type 2 Trial in Worldwide (Dulaglutide, Placebo)
Completed
- Cardiovascular Disease
- Diabetes Mellitus, Type 2
- Dulaglutide
- Placebo
-
Mobile, Alabama
- +300 more
Sep 18, 2019
Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)
Completed
- Cardiovascular Disease
- +4 more
- Lorcaserin hydrochloride
- Placebo
-
Alexander City, Alabama
- +498 more
Jun 27, 2019
Cardiovascular Disease Trial in Worldwide (bococizumab (PF-04950615), Placebo)
Terminated
- Cardiovascular Disease
- bococizumab (PF-04950615)
- Placebo
-
Athens, Alabama
- +1595 more
Apr 18, 2019
Cardiovascular Disease, Hypertension, Diabetes Trial in Dallas (Lay Health Promoter (LHP) with maintenance)
Completed
- Cardiovascular Disease
- +3 more
- Lay Health Promoter (LHP) with maintenance
-
Dallas, TexasUT Southwestern Medical Center
Feb 8, 2019
Cardiovascular Disease Trial in Worldwide (bococizumab (PF-04950615), Placebo)
Terminated
- Cardiovascular Disease
- bococizumab (PF-04950615)
- Placebo
-
Athens, Alabama
- +1745 more
Jun 14, 2018
Cardiovascular Disease Trial in Mexico, United States (Febuxostat, Allopurinol)
Completed
- Cardiovascular Disease
-
Decatur, Georgia
- +202 more
Jun 12, 2018
Psoriasis, Cardiovascular Disease Trial in United States (Adalimumab (Humira), Placebo Injection, NB-UVB phototherapy)
Completed
- Psoriasis
- Cardiovascular Disease
- Adalimumab (Humira)
- +2 more
-
Sacramento, California
- +8 more
Apr 23, 2018
Psoriasis, Cardiovascular Disease Trial in United States (Adalimumab)
Completed
- Psoriasis
- Cardiovascular Disease
-
Sacramento, California
- +8 more
Apr 23, 2018
Type 2 Diabetes, Cardiovascular Disease Trial in Worldwide (TAK-875, TAK-875 Placebo)
Terminated
- Type 2 Diabetes
- Cardiovascular Disease
- TAK-875
- TAK-875 Placebo
-
Birmingham, Alabama
- +587 more
Oct 15, 2015
Cardiovascular Disease Trial in United States (Vascular surgery with best medical treatment, Coronary artery bypass grafting
Completed
- Cardiovascular Disease
- Vascular surgery with best medical treatment
- +2 more
-
Tucson, Arizona
- +17 more
Jun 25, 2015
Type 2 Diabetes, Cardiovascular Disease Trial in Worldwide (Aliskiren, Placebo)
Terminated
- Type 2 Diabetes Mellitus
- Cardiovascular Disease
- Aliskiren
- Placebo
-
Birmingham, Alabama
- +777 more
Apr 1, 2014
Type 2 Diabetes, Cardiovascular Disease, Inadequate Glycaemic Control Trial in Worldwide (Dapagliflozin, Placebo)
Completed
- Type 2 Diabetes Mellitus
- +2 more
- Dapagliflozin
- Placebo
-
Birmingham, Alabama
- +134 more
Dec 18, 2013
Type 2 Diabetes, Cardiovascular Disease, Hypertension Trial in Worldwide (Dapagliflozin, Placebo)
Completed
- Type 2 Diabetes Mellitus
- +3 more
- Dapagliflozin
- Placebo
-
Gulf Shores, Alabama
- +140 more
Sep 24, 2013
What is the Optimal Method for Ischemia Evaluation in WomeN?
Completed
- Coronary Artery Disease
- +4 more
-
Tucson, Arizona
- +42 more
Jul 31, 2012
Atherosclerosis, Cardiovascular Disease Trial in Dallas (GW856553)
Completed
- Atherosclerosis
- Cardiovascular Disease
-
Dallas, TexasGSK Investigational Site
May 31, 2012
Same Day Versus Next Day Discharge: Ambulatory Closure Device
Completed
- Cardiovascular Disease
- discharge vs. overnight stay
-
New York, New York
- +1 more
Jul 26, 2011
Cardiovascular Disease Trial in Dallas (dialysis)
Unknown status
- Cardiovascular Disease
- dialysis
-
Dallas, TexasDallas VA Medical Center
Feb 24, 2010